Daniel James Tiede, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth Ave N, Centracare Clinic, St Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 |
Bernard Rudolph Erickson, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth Ave N, Centracare Clinic, St Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 |
Mark E Johnson, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth Ave N, Centracare Clinic, St Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 |
Jacob R Dutcher, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth Ave N, St Cloud, MN 56303 Phone: 320-656-7020 |
Wade Thomas Schmidt, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth Ave N, Centracare Clinic, St Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 |
Keith G Lurie, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1200 Sixth Ave N, Centracare Clinic, St Cloud, MN 56303 Phone: 320-252-5131 |
Julia Vladimironva Montgomery, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth Ave N, St Cloud, MN 56303 Phone: 320-656-7020 |
News Archive
People diagnosed with breast, bowel and ovarian cancers and non-Hodgkin's lymphoma are today twice as likely to survive for at least 10 years as those diagnosed in the early 1970s according to new figures1 released by Cancer Research UK.
Recovering addicts who avoid coping with stress succumb easily to substance use cravings, making them more likely to relapse during recovery, according to behavioral researchers.
The Johns Hopkins researchers who first showed that the commonly used blood pressure drug losartan may help prevent life-threatening aneurysms of the aorta in patients with Marfan syndrome have now discovered new clues about the precise mechanism behind the drug's protective effects.
Researchers at the Johns Hopkins School of Medicine have successfully edited the genome of human- induced pluripotent stem cells, making possible the future development of patient-specific stem cell therapies. Reporting this week in Cell Stem Cell, the team altered a gene responsible for causing the rare blood disease paroxysmal nocturnal hemoglobinuria, or PNH, establishing for the first time a useful system to learn more about the disease.
› Verified 3 days ago